RoundTable Healthcare Partners Sells Symmetry Surgical to Aspen Surgical

RoundTable Healthcare Partners Sells Symmetry Surgical to Aspen Surgical

by | Oct 27, 2022 2:58 pm | Medical Devices, Private Equity | 0 comments

Aspen Surgical, a portfolio company of Audax Private Equity, announced that it purchased Symmetry Surgical Inc. The company was sold by RoundTable Healthcare Partners, LLC. Terms were not disclosed.  William Blair and Baird acted as financial advisors to Symmetry. Gibson, Dunn & Crutcher LLP acted as exclusive legal advisor to RoundTable. The sale was completed on October 27, 2022.  Founded in 1999, Aspen Surgical is a medical equipment manufacturer based out of Caledonia, Michigan. It manufactures products such as blades/scalpels, needles, wound closures and surgical clamps.  Symmetry Surgical develops and delivers innovative surgical instruments for clinicians. It... Read More »
More Medical Device Deals in May

More Medical Device Deals in May

by | May 18, 2020 3:34 pm | Medical Devices | 0 comments

The market is still busy for healthcare technology sectors, including medical device companies. So far, 29 deals have been announced in 2020 in the Medical Device sector, compared with 32 a year ago, according to our Deal Search Online database. Yes, that’s a slight drop, year over year, but nothing compared with some of the services sectors. Through mid-May, five deals targeting medical device companies are on the books. The latest announcement was from Smiths Medical, the U.S. subsidiary of Smiths Group plc (OTC: SMGKF). The parent company is a British diversified engineering business with operation in more than 50 countries. Smiths Medical, based in Plymouth, Minnesota, is a... Read More »

Mylan Adds Topical Pharmaceuticals Business

by | May 18, 2016 8:04 am | Pharmaceuticals, Private Equity | 0 comments

Mylan NV (NASDAQ: MYL) still has money to spend, following its $9.9 billion deal for Swedish drug maker Meda AB in February. On Friday, May 13, RoundTable Healthcare Partners announced that its portfolio company, Renaissance Acquisition Holdings, LLC, had agreed to sell its non-sterile topical drug business to Mylan for $950 million, plus additional contingent payments of up to $50 million. The topical division is a specialty pharmaceutical business focused on manufacturing, developing, sales and marketing of branded and generic drug products. The acquisition brings a complementary portfolio of approximately 25 branded and generic topical products, an active pipeline of approximately 25... Read More »